valine and bortezomib

valine has been researched along with bortezomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, Y; Fukushima, T; Iwao, H; Kawanami, T; Masaki, Y; Miki, M; Motoo, Y; Nakajima, A; Nakajima, H; Nakamura, T; Okazaki, T; Sakai, T; Sato, T; Sawaki, T; Tanaka, M; Umehara, H1
Harrison, SJ; Slavin, MA; Teh, BW; Worth, LJ1

Other Studies

2 other study(ies) available for valine and bortezomib

ArticleYear
Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
    Anticancer research, 2012, Volume: 32, Issue:12

    Topics: Acyclovir; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Retrospective Studies; Valacyclovir; Valine; Virus Activation

2012
Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:7

    Topics: Acyclovir; Aged; Antineoplastic Agents; Antiviral Agents; Bortezomib; Cohort Studies; Female; Hematopoietic Stem Cell Transplantation; Herpesvirus 3, Human; Humans; Male; Middle Aged; Multiple Myeloma; Outcome Assessment, Health Care; Time Factors; Transplantation, Autologous; Valacyclovir; Valine; Varicella Zoster Virus Infection

2016